Safety, Pharmacokinetics, and Pharmacodynamics Study of Single Dose of CNTO 3649 in Healthy Adult Men and Multiple Doses of CNTO 3649 in Participants With Type 2 Diabetes Mellitus

NCT02224118 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

64

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy
Diabetes Mellitus, Type 2

Interventions

DRUG: CNTO 3649 10 mcg/kg
DRUG: CNT0 3649 30 mcg/kg
DRUG: CNTO 3649 100 mcg/kg
DRUG: CNTO 3649 300 mcg/kg
DRUG: Placebo

Sponsor

Janssen Pharmaceutical K.K.